Position in MRK
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$11,125,401
+$611,815 QoQ
Shares Held
86,579
-0.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
5.21%
of 13F equity value
Holder Rank
#712
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FLC Capital Advisors holds $21,615,806 across 11 Drug Manufacturers - General names. MRK ranks #1 (51.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
This page
|
86,579 | $11,125,401 | |
| 2 | JNJ |
Johnson & Johnson
|
13,403 | $3,403,959 | |
| 3 | PFE |
Pfizer Inc
|
66,092 | $1,591,495 | |
| 4 | ABBV |
AbbVie Inc.
|
6,063 | $1,525,693 | |
| 5 | LLY |
ELI LILLY & Co
|
1,111 | $1,332,566 | |
| 6 | AMGN |
Amgen Inc
|
2,086 | $755,382 | |
| 7 | NVS |
Novartis AG
|
3,066 | $480,503 | |
| 8 | NVO |
Novo Nordisk A S
|
9,824 | $470,962 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,125,401 | 86,579 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $10,513,586 | 87,402 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $9,385,507 | 89,165 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $7,268,925 | 86,607 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $6,691,315 | 84,529 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $7,145,434 | 79,606 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $7,861,506 | 79,026 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $9,255,707 | 81,505 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $10,460,481 | 84,495 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $11,163,365 | 84,603 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $9,328,950 | 85,571 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $8,531,878 | 82,874 | Shares | Sole | 2024-01-18 | |
| 2023-06-30 | $9,618,564 | 83,357 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $8,868,351 | 83,357 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $9,270,649 | 83,557 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $7,203,593 | 83,646 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $7,675,419 | 84,188 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $6,993,859 | 85,239 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $5,751,832 | 75,050 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $5,526,068 | 73,573 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $5,563,121 | 71,533 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $5,423,901 | 70,358 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $5,386,282 | 65,847 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $5,185,704 | 62,516 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $4,684,189 | 60,574 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $4,411,891 | 57,342 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||